Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Express Scripts
Chubb
Farmers Insurance
UBS
Fish and Richardson
QuintilesIMS
US Department of Justice

Generated: January 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022014

« Back to Dashboard

NDA 022014 describes EVAMIST, which is a drug marketed by Perrigo Pharma Intl and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the EVAMIST profile page.

The generic ingredient in EVAMIST is estradiol. There are seventy-five drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 022014
Tradename:EVAMIST
Applicant:Perrigo Pharma Intl
Ingredient:estradiol
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 022014
Mechanism of ActionEstrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 022014
Suppliers and Packaging for NDA: 022014
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EVAMIST estradiol SPRAY;TRANSDERMAL 022014 NDA Paddock Laboratories, LLC 0574-2067 0574-2067-00 56 SPRAY in 1 VIAL, MULTI-DOSE (0574-2067-00)
EVAMIST estradiol SPRAY;TRANSDERMAL 022014 NDA Paddock Laboratories, LLC 0574-2067 0574-2067-27 56 SPRAY in 1 VIAL, MULTI-DOSE (0574-2067-27)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;TRANSDERMALStrength1.53MG/SPRAY
Approval Date:Jul 27, 2007TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Jul 31, 2022Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 022014

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Perrigo Pharma Intl EVAMIST estradiol SPRAY;TRANSDERMAL 022014-001 Jul 27, 2007 ➤ Sign Up ➤ Sign Up
Perrigo Pharma Intl EVAMIST estradiol SPRAY;TRANSDERMAL 022014-001 Jul 27, 2007 ➤ Sign Up ➤ Sign Up
Perrigo Pharma Intl EVAMIST estradiol SPRAY;TRANSDERMAL 022014-001 Jul 27, 2007 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Cipla
Dow
Harvard Business School
US Department of Justice
Merck
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.